Zenith Healthcare Ltd
BSE:530665
Net Margin
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Peer Comparison
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| IN |
|
Zenith Healthcare Ltd
BSE:530665
|
177.3m INR |
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
986.9B USD |
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
596.5B USD |
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
293B CHF |
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
249.7B CHF |
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
240.5B GBP |
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
305.9B USD |
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD |
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK |
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
156.9B USD |
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
125.6B USD |
Loading...
|
Market Distribution
| Min | -305 007.7% |
| 30th Percentile | 2.1% |
| Median | 5.8% |
| 70th Percentile | 11.6% |
| Max | 1 221 633.3% |
Other Profitability Ratios
Zenith Healthcare Ltd
Glance View
Zenith Healthcare Ltd. engages in the manufacture of pharmaceuticals formulation in the forms of tablets, capsules, oral liquids and injections. The company is headquartered in Ahmedabad, Gujarat. The firm offers its products across various therapeutic segments, including antibiotics and anti-infective, gastrointestinal tract, analgesic/anti-inflammatory, cardiovascular system, respiratory, ophthalmology, bio-technical products, oncology, anti-retroviral, central nervous system, nutrition, genito urinary system and skin. Its products across antibiotics and anti-infective category includes Roxythromycin Tablets, Ciprofloxacin Tablets, Azithromycine Dihydrate Suspension and Azithromycin Oral Suspension. Its product across gastrointestinal category includes Ranitidine Hydrochloride Tablets. Its product across cardiovascular system includes Lisinopril Tablets. Its products across analgesic category include Paracetamol and Aceclofenac Tablets. The company offers contract manufacturing of all dosage forms.
See Also
Net Margin is calculated by dividing the Net Income by the Revenue.
The current Net Margin for Zenith Healthcare Ltd is -0.5%, which is below its 3-year median of 0.5%.
Over the last 3 years, Zenith Healthcare Ltd’s Net Margin has decreased from 1.6% to -0.5%. During this period, it reached a low of -2.7% on Dec 31, 2024 and a high of 2% on Sep 30, 2023.
